Trials / Completed
CompletedNCT02779868
Omega-3 Supplementation in Cervix Cancer Patients Undergoing Chemoradiotherapy
Effect of Omega-3 Supplementation on Body Composition, Functional Capacity, Inflammatory Profile and Quality of Life in Cervix Cancer Patients Undergoing Chemoradiotherapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Brazilian National Cancer Institute · Other Government
- Sex
- Female
- Age
- 20 Years – 59 Years
- Healthy volunteers
- Not accepted
Summary
Cancer cachexia is a complex metabolic process affecting up to 80% of patients suffering from an advanced-stage cancer. Moreover, 20 to 40% of all cancer deaths are caused directly by cachexia. Recently, omega-3 fatty acids have gained interest for their beneficial effects in cancer cachexia. Moreover, nutritional supplementation enriched with omega-3 could potentially maintain body weight in cancer patients undergoing intensive treatment. The investigators aims in this study is to evaluate the effect of omega-3 supplementation on body composition, functional capacity, inflammatory profile and quality of life in cervix cancer patients undergoing chemoradiotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Omega-3 | patients included in this group will take 2g (4 capsules) per day of eicosapentaenoic acid. |
| DIETARY_SUPPLEMENT | Olive oil | patients included in this group will take 4 capsules per day of olive oil. |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2017-07-01
- Completion
- 2017-07-01
- First posted
- 2016-05-23
- Last updated
- 2017-07-25
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02779868. Inclusion in this directory is not an endorsement.